InvestorsHub Logo
icon url

nidan7500

05/06/23 8:50 AM

#414003 RE: Joseph_K #413995

J_K

I think most of that growth will relate to aspects of "commercialization," not to the drug-testing that was the company's sole focus until recently.



Time must be spent discovering/understanding what we currently do not know, we do not know. AVXL will (maybe) be best known for that discovery process when it's history is written.
icon url

tredenwater2

05/06/23 11:54 AM

#414024 RE: Joseph_K #413995

Joseph why dont you enter the amount of super responders from our Ph 2a with the WT S1 repceptor % and see what chat says about the odds of super responders in our Ph 3 Alzheimer’s trial. This may help put many minds at rest and who knows, maybe it exceeds 76!